Shelley A. Hartman

About

Shelley A. Hartman is a biotech executive and co-founder of Aegle Therapeutics, an extracellular-vesicle therapeutics company focused on regenerative medicine and rare disease. Aegle's current company page says she became CEO in 2019, while an older public Aegle management page says she has served as CEO since August 2014 and became Chairman of the Board in January 2020. Earlier in her career, she was CEO of LifeSync and previously spent 19 years in investment banking, including seven years as a Managing Director at Goldman Sachs.

Areas of interest